Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ: AVIR · IEX Real-Time Price · USD

3.670

+0.060 (1.66%)

At close: May 31, 2024, 4:00 PM

3.610

-0.060 (-1.63%)

After-hours: May 31, 2024, 4:06 PM EDT

Atea Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-135.96	-115.91	121.19	-10.95	-14.03	Upgrade
Depreciation & Amortization	0.42	0.26	0.03	0.02	0.02	Upgrade
Share-Based Compensation	49.43	46.72	39.62	7.46	0.62	Upgrade
Other Operating Activities	0.72	-52.05	-247.85	300.21	0.56	Upgrade
Operating Cash Flow	-85.4	-120.98	-87.01	296.73	-12.83	Upgrade
Capital Expenditures	0	-1.94	-0	-0.03	-0	Upgrade
Change in Investments	40.3	-453.47	0	0	0	Upgrade
Investing Cash Flow	40.3	-455.41	-0	-0.03	-0	Upgrade
Share Issuance / Repurchase	0.26	0.37	1.47	317.63	0	Upgrade
Other Financing Activities	-	-	-	214.12	-	Upgrade
Financing Cash Flow	0.26	0.37	1.47	531.75	0	Upgrade
Net Cash Flow	-44.84	-576.02	-85.54	828.46	-12.83	Upgrade
Free Cash Flow	-85.4	-122.93	-87.01	296.71	-12.83	Upgrade
Free Cash Flow Margin	-	-	-24.76%	610.10%	-	Upgrade
Free Cash Flow Per Share	-1.02	-1.48	-1.05	13.74	-1.27	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).